PRECIGEN, INC. - Common Stock (PGEN)

CUSIP: 74017N105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
353,007,843
Total 13F shares
135,952,580
Share change
-7,255,468
Total reported value
$182,176,824
Put/Call ratio
41%
Price per share
$1.34
Number of holders
154
Value change
-$10,848,844
Number of buys
57
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 74017N105?
CUSIP 74017N105 identifies PGEN - PRECIGEN, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Third Security, LLC
13F
Company
24%
83,465,566
$176,112,000 31 Mar 2022
13F
Ares Trading S.A.
3/4/5
10%+ Owner
class O/S missing
20,647,152
$29,112,484 12 Oct 2021
VANGUARD GROUP INC
13F
Company
2.2%
7,795,407
$16,449,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
2%
7,225,423
$15,246,000 31 Mar 2022
13F
MILLER VALUE PARTNERS, LLC
13F
Company
1.8%
6,391,355
$13,485,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.4%
4,933,435
$10,410,000 31 Mar 2022
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
1%
3,604,395
$7,605,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.64%
2,260,339
$4,769,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.5%
1,754,308
$3,702,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.49%
1,728,560
$3,647,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.34%
1,187,590
$2,506,000 31 Mar 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.33%
1,178,978
$2,488,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
0.32%
1,142,509
$2,411,000 31 Mar 2022
13F
MSD Partners, L.P.
13F
Company
0.27%
960,000
$2,026,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.26%
920,275
$1,942,000 31 Mar 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.25%
868,556
$1,833,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.24%
849,464
$1,792,000 31 Mar 2022
13F
SEI INVESTMENTS CO
13F
Company
0.23%
817,315
$1,725,000 31 Mar 2022
13F
HRT FINANCIAL LP
13F
Company
0.21%
731,215
$1,542,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.2%
723,138
$1,526,000 31 Mar 2022
13F
GMT CAPITAL CORP
13F
Company
0.19%
668,830
$1,411,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.19%
662,332
$1,398,000 31 Mar 2022
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.18%
628,901
$1,327,000 31 Mar 2022
13F
Qube Research & Technologies Ltd
13F
Company
0.17%
598,686
$1,263,000 31 Mar 2022
13F
MARSHALL WACE, LLP
13F
Company
0.17%
591,863
$1,248,000 31 Mar 2022
13F
First Washington CORP
13F
Company
0.17%
587,964
$1,241,000 31 Mar 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.16%
560,611
$1,183,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.15%
528,819
$1,110,000 31 Mar 2022
13F
NORGES BANK
13F
Company
0.14%
504,590
$1,064,685 31 Mar 2022
13F
Graham Capital Management, L.P.
13F
Company
0.14%
483,223
$1,019,000 31 Mar 2022
13F
AXA S.A.
13F
Company
0.13%
463,900
$978,829 31 Mar 2022
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.09%
329,838
$696,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.09%
318,587
$672,000 31 Mar 2022
13F
Patient Capital Management, LLC
13F
Company
0.08%
298,200
$629,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.08%
278,221
$587,000 31 Mar 2022
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.08%
269,202
$568,000 31 Mar 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.08%
265,600
$560,000 31 Mar 2022
13F
GROUP ONE TRADING LLC
13F
Company
0.07%
240,011
$506,000 31 Mar 2022
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.06%
221,132
$467,000 31 Mar 2022
13F
Swiss National Bank
13F
Company
0.06%
220,000
$464,000 31 Mar 2022
13F
Northeast Financial Consultants Inc
13F
Company
0.06%
214,209
$452,000 31 Mar 2022
13F
BANK OF MONTREAL /CAN/
13F
Company
0.06%
212,610
$449,000 31 Mar 2022
13F
FMR LLC
13F
Company
0.06%
201,807
$426,000 31 Mar 2022
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.05%
193,791
$409,000 31 Mar 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
0.05%
182,358
$389,000 31 Mar 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.05%
179,680
$379,000 31 Mar 2022
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.05%
178,900
$377,000 31 Mar 2022
13F
Caption Management, LLC
13F
Company
0.05%
160,000
$338,000 31 Mar 2022
13F
Cetera Investment Advisers
13F
Company
0.04%
149,688
$316,000 31 Mar 2022
13F
LexAurum Advisors, LLC
13F
Company
0.04%
148,871
$314,000 31 Mar 2022
13F

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2022

As of 30 Jun 2022, PRECIGEN, INC. - Common Stock (PGEN) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 135,952,580 shares. The largest 10 holders included Third Security, LLC, BlackRock Inc., MILLER VALUE PARTNERS, LLC, VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and RENAISSANCE TECHNOLOGIES LLC. This page lists 154 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
159
Q2 2022 holders
154
Holder diff
-5
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .